218 related articles for article (PubMed ID: 27593184)
1. Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.
Mohammed AM; Faisal W; Saleh KI; Osman SK
Curr Drug Deliv; 2017; 14(7):926-934. PubMed ID: 27593184
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
3. Self-assembling Organogels Loaded with Tenoxicam for Local Intensive Pain and Inflammation Cure: In Vitro and In Vivo Correlation.
Osman SK; Yassin TM; Abdelzaher A; Ahmed F; Mohammed AM; Abdellatif AAH; Saleh KI; Mahdi WA; Alshehri S; Hamd MAE; Sarhan H
AAPS PharmSciTech; 2024 Jan; 25(1):18. PubMed ID: 38263347
[TBL] [Abstract][Full Text] [Related]
4. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
5. Organogels in Drug Delivery: A Special Emphasis on Pluronic Lecithin Organogels.
Alsaab H; Bonam SP; Bahl D; Chowdhury P; Alexander K; Boddu SH
J Pharm Pharm Sci; 2016; 19(2):252-73. PubMed ID: 27518174
[TBL] [Abstract][Full Text] [Related]
6. Propolis organogel as a novel topical delivery system for treating wounds.
Balata G; El Nahas HM; Radwan S
Drug Deliv; 2014 Feb; 21(1):55-61. PubMed ID: 24295500
[TBL] [Abstract][Full Text] [Related]
7. The use of Pluronic lecithin organogels in the transdermal delivery of drugs.
Bramwell BL; Williams LA
Int J Pharm Compd; 2012; 16(1):62-3. PubMed ID: 23050314
[TBL] [Abstract][Full Text] [Related]
8. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs.
Almeida H; Amaral MH; Lobão P; Lobo JM
J Pharm Pharm Sci; 2012; 15(4):592-605. PubMed ID: 23106961
[TBL] [Abstract][Full Text] [Related]
9. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis.
Mady FM; Essa H; El-Ammawi T; Abdelkader H; Hussein AK
Drug Des Devel Ther; 2016; 10():1101-10. PubMed ID: 27022248
[TBL] [Abstract][Full Text] [Related]
10. Optimization and evaluation of pluronic lecithin organogels as a transdermal delivery vehicle for sinomenine.
Ba W; Li Z; Wang L; Wang D; Liao W; Fan W; Wu Y; Liao F; Yu J
Pharm Dev Technol; 2016 Aug; 21(5):535-45. PubMed ID: 25757643
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
Boddu SH; Bonam SP; Jung R
Drug Dev Ind Pharm; 2015 Apr; 41(4):605-12. PubMed ID: 24517574
[TBL] [Abstract][Full Text] [Related]
12. Pluronic lecithin organogel (PLO) of diltiazem hydrochloride: effect of solvents/penetration enhancers on ex vivo permeation.
Parhi R; Suresh P; Pattnaik S
Drug Deliv Transl Res; 2016 Jun; 6(3):243-53. PubMed ID: 26754742
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of a novel ricinoleic acid poloxamer gel system for transdermal delivery.
Boddu SH; Alsaab H; Umar S; Bonam SP; Gupta H; Ahmed S
Int J Pharm; 2015 Feb; 479(1):207-11. PubMed ID: 25542985
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
Boddu SH; Bonam SP; Wei Y; Alexander K
Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptan.
Agrawal V; Gupta V; Ramteke S; Trivedi P
AAPS PharmSciTech; 2010 Dec; 11(4):1718-25. PubMed ID: 21128126
[TBL] [Abstract][Full Text] [Related]
16. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
17. Design, Development and
Chauhan S; Jhawat V; Singh RP; Yadav A; Garg V
Recent Adv Drug Deliv Formul; 2024; 18(1):50-60. PubMed ID: 38284692
[TBL] [Abstract][Full Text] [Related]
18. Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogel.
Woodall R; Arnold JJ; McKay D; Asbill CS
Int J Pharm Compd; 2013; 17(3):247-53. PubMed ID: 24046940
[TBL] [Abstract][Full Text] [Related]
19. An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion.
Sallam MA; Motawaa AM; Mortada SM
Drug Dev Ind Pharm; 2015 Jan; 41(1):141-7. PubMed ID: 24171693
[TBL] [Abstract][Full Text] [Related]
20. Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.
Chang CE; Hsieh CM; Chen LC; Su CY; Liu DZ; Jhan HJ; Ho HO; Sheu MT
Drug Deliv; 2018 Nov; 25(1):632-643. PubMed ID: 29463123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
